ISpecimen Income from Continuous Operations 2020-2025 | ISPC
ISpecimen income from continuous operations from 2020 to 2025. Income from continuous operations can be defined as a company's total income or loss before discontinued operations, extraordinary items, preferred stock dividends and accounting change
| ISpecimen Annual Income from Continuous Operations (Millions of US $) |
|
|---|---|
| 2024 | $-12 |
| 2023 | $-11 |
| 2022 | $-10 |
| 2021 | $-9 |
| 2020 | $-5 |
| 2019 | $-5 |
| ISpecimen Quarterly Income from Continuous Operations (Millions of US $) |
|
|---|---|
| 2025-03-31 | $-2 |
| 2024-12-31 | $-6 |
| 2024-09-30 | $-1 |
| 2024-06-30 | $-2 |
| 2024-03-31 | $-3 |
| 2023-12-31 | $-3 |
| 2023-09-30 | $-2 |
| 2023-06-30 | $-3 |
| 2023-03-31 | $-2 |
| 2022-12-31 | $-2 |
| 2022-09-30 | $-3 |
| 2022-06-30 | $-3 |
| 2022-03-31 | $-2 |
| 2021-12-31 | $-2 |
| 2021-09-30 | $-2 |
| 2021-06-30 | $-1 |
| 2021-03-31 | $-4 |
| 2020-12-31 | |
| 2020-09-30 | $-1 |
| 2020-06-30 | $0 |
| 2019-12-31 | |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Services | $0.004B | $0.009B |
| iSpecimen Inc. offers an online marketplace for human biospecimens, connecting life scientists in commercial and non-profit organizations with healthcare providers which have access to patients and specimens needed for medical discovery. iSpecimen Inc. is based in LEXINGTON, Mass. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Danaher (DHR) | United States | $141.127B | 26.17 |
| CVS Health (CVS) | United States | $79.026B | 9.85 |
| Elevance Health (ELV) | United States | $61.847B | 8.32 |
| Cencora (COR) | United States | $55.889B | 19.44 |
| DiDi Global (DIDIY) | China | $23.438B | 24.90 |
| Labcorp Holdings (LH) | United States | $21.888B | 17.27 |
| Natera (NTRA) | United States | $18.376B | 0.00 |
| BioMerieux (BMXMF) | France | $17.068B | 0.00 |
| EUROFINS SCIENT (ERFSF) | Luxembourg | $15.072B | 0.00 |
| ICON (ICLR) | Ireland | $13.441B | 12.93 |
| CochLear (CHEOY) | Australia | $13.183B | 0.00 |
| Solventum (SOLV) | United States | $12.410B | 13.14 |
| Medpace Holdings (MEDP) | United States | $11.886B | 31.46 |
| Revvity (RVTY) | United States | $10.400B | 18.04 |
| Viatris (VTRS) | United States | $10.340B | 3.55 |
| Sonic Healthcare (SKHHY) | Australia | $8.699B | 0.00 |
| Charles River Laboratories (CRL) | United States | $8.198B | 16.06 |
| HealthEquity (HQY) | United States | $7.874B | 34.49 |
| Avantor (AVTR) | United States | $7.741B | 11.36 |
| Caris Life Sciences,�Inc (CAI) | United States | $7.133B | 0.00 |
| Bausch + Lomb (BLCO) | Canada | $4.776B | 32.14 |
| Amplifon S.p.A (AMFPF) | Italy | $3.890B | 21.30 |
| BrightSpring Health Services (BTSG) | United States | $3.453B | 26.54 |
| Sotera Health (SHC) | United States | $3.165B | 17.98 |
| GeneDx Holdings (WGS) | United States | $2.899B | 66.84 |
| Surgery Partners (SGRY) | United States | $2.727B | 35.47 |
| Alignment Healthcare (ALHC) | United States | $2.568B | 0.00 |
| Organon (OGN) | United States | $2.535B | 2.69 |
| Concentras Parent (CON) | United States | $2.497B | 14.43 |
| Progyny (PGNY) | United States | $1.928B | 42.43 |
| Premier (PINC) | United States | $1.751B | 13.29 |
| PACS (PACS) | United States | $1.618B | 0.00 |
| GoodRx Holdings (GDRX) | United States | $1.618B | 32.36 |
| Ardent Health (ARDT) | United States | $1.462B | 6.23 |
| Teladoc Health (TDOC) | United States | $1.226B | 0.00 |
| Establishment Labs Holdings (ESTA) | $1.195B | 0.00 | |
| Pediatrix Medical (MD) | United States | $1.029B | 7.83 |
| Ryman Healthcare (RYHTY) | New Zealand | $0.970B | 0.00 |
| QDM (QDMI) | Hong Kong, SAR China | $0.882B | 302.50 |
| Agilon Health (AGL) | United States | $0.704B | 0.00 |
| AMN Healthcare Services Inc (AMN) | United States | $0.683B | 6.40 |
| CareDx (CDNA) | United States | $0.680B | 10.63 |
| Performant Healthcare (PHLT) | United States | $0.598B | 0.00 |
| Embecta (EMBC) | United States | $0.582B | 3.92 |
| Nutex Health (NUTX) | United States | $0.467B | 7.06 |
| Auna S.A (AUNA) | Luxembourg | $0.457B | 10.28 |
| LifeMD (LFMD) | United States | $0.452B | 0.00 |
| Sonida Senior Living (SNDA) | United States | $0.451B | 0.00 |
| Omada Health (OMDA) | $0.448B | 0.00 | |
| So-Young (SY) | China | $0.438B | 0.00 |
| SBC Medicals (SBC) | United States | $0.433B | 0.00 |
| InnovAge Holding (INNV) | United States | $0.423B | 0.00 |
| COMPASS Pathways (CMPS) | United Kingdom | $0.406B | 0.00 |
| Oncology Institute (TOI) | United States | $0.333B | 0.00 |
| Enhabit (EHAB) | United States | $0.330B | 27.17 |
| Beauty Health (SKIN) | United States | $0.193B | 0.00 |
| DocGo (DCGO) | United States | $0.136B | 22.17 |
| Sera Prognostics (SERA) | United States | $0.102B | 0.00 |
| Ascend Wellness Holdings (AAWH) | United States | $0.080B | 0.00 |
| NeueHealth (NEUE) | United States | $0.061B | 0.00 |
| IceCure Medical (ICCM) | Israel | $0.059B | 0.00 |
| Biodesix (BDSX) | United States | $0.053B | 0.00 |
| KindlyMD (NAKA) | United States | $0.046B | 0.00 |
| ModivCare (MODV) | United States | $0.039B | 0.00 |
| NeuroOne Medical Technologies (NMTC) | United States | $0.038B | 0.00 |
| Basel Medical Group (BMGL) | Singapore | $0.037B | 0.00 |
| OSR Holdings (OSRH) | United States | $0.012B | 0.00 |
| BioNexus Gene Lab (BGLC) | $0.012B | 0.00 | |
| Intelligent Bio Solutions (INBS) | United States | $0.010B | 0.00 |
| Co-Diagnostics (CODX) | United States | $0.008B | 0.00 |
| SeaStar Medical Holding (ICU) | United States | $0.007B | 0.00 |
| XWELL (XWEL) | United States | $0.006B | 0.00 |
| Pheton Holdings (PTHL) | China | $0.005B | 0.00 |
| Aclarion (ACON) | United States | $0.004B | 0.00 |
| NewGenIvf Group (NIVF) | Thailand | $0.002B | 0.00 |
| INVO Fertility (IVF) | United States | $0.001B | 0.00 |
| Cano Health (CANOQ) | United States | $0.000B | 0.00 |